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Abstract 
 Thymic epithelial cells (TECs) are required for the development and differentiation of T cells 
and are sufficient for the positive and negative selection of developing T cells.  Although TECs play 
a critical role in T cell biology, simple, efficient and readily scalable methods for the transfection of 
TEC lines and primary TECs have not been described.  We tested the efficiency of Nucleofection for 
the transfection of 4 different mouse thymic epithelial cell lines that had been derived from cortical 
or medullary epithelium.  We also tested primary mouse thymic epithelial cells isolated from fetal 
and postnatal stages.  We found that Nucleofection was highly efficient for the transfection of thymic 
epithelial cells, with transfection efficiencies of 30-70% for the cell lines and 15-35% for primary 
TECs with low amounts of cell death.  Efficient transfection by Nucleofection can be performed with 
established cortical and medullary thymic epithelial cell lines as well as primary TECs isolated from 
E15.5 day fetal thymus or postnatal day 3 or 30 thymus tissue.  The high efficiency of Nucleofection 
for TEC transfection will enable the use of TEC lines in high throughput transfection studies and 
simplifies the transfection of primary TECs for in vitro or in vivo analysis.    
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Background 
 The non-hematopoietic epithelial cells of the thymus form a complex microenvironment that 
supports the normal development and differentiation of T cells.  Developmentally, thymic epithelial 
cells (TECs) are derived exclusively from the pharyngeal endoderm [1].  During thymus 
organogenesis TEC progenitors differentiate into medullary or cortical cell types and these two 
lineages form histologically and functionally distinct compartments within the thymus [2].   
Interactions between the non-hematopoietic TECs and differentiating T-cells are required for normal 
T cell differentiation, maturation and selection [3].  Due to their essential role in T cell development, 
understanding the process of thymic epithelial cell specification, differentiation and maintenance will 
be required to understand T cell biology.  TECs are also of clinical interest due to the progressive 
loss of thymus function during normal human aging.  Slowing or reversing the loss of TECs may 
prolong robust T cell function in aging individuals.  In addition, a greater understanding of thymic 
epithelial cell specification and differentiation during development may pave the way for the 
generation of TEC stem cells that can be transplanted to restore or supplement endogenous thymic 
function in ageing individuals or those with congenital thymus dysgenesis or agenesis [4-6].   
 Given the importance of thymic epithelial cells in basic and clinical immunology several 
approaches have been developed for their analysis in vivo and in cell culture.  Genetic studies in mice 
and humans have identified a number of genes required for TEC formation, differentiation and 
function [7-11].  In addition, cell labeling, tissue grafting, cell culture, and organ culture approaches 
have been developed for studies of embryonic TEC lineage specification, differentiation or TEC-
thymocyte interactions [12-15].  Primary thymic epithelial cell cultures can be readily established 
from fetal or adult thymus and many thymic epithelial cell lines are available.  Unfortunately, it is 
quite difficult to transfect primary TECs or established TEC lines using simple approaches such as 
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lipofection.  This difficulty has been noted previously [16] and many studies of TEC gene promoters 
or TEC transcription factors have been performed in HELA or other non-TEC cell lines [16-21].  
Although methods for TEC transfection via retroviral vectors [22] have been developed, these 
methods are cumbersome since they require construction of viral vectors and the production of high 
titer stocks for each construct.  This makes viral approaches problematic in cases where a large 
number of independent constructs must be tested such as in promoter analysis or in studies of protein 
functional domains.   
 To remove this current limitation to the experimental analysis of TEC biology, we tested 
whether nucleofection can efficiently transfect plasmid constructs into 4 independent TEC lines as 
well as primary TECs isolated from three different developmental stages.  Nucleofection is a 
relatively new highly optimized electroporation method that enables high efficiency electroporation 
of a wide range of cell types including primary cells and postmitotic cells [23].  Nucleofection has 
been shown to efficiently transfect a wide range of cell types including stem cells, progenitors and/or 
fully differentiated cells isolated from the nervous system, the immune system, smooth muscle, 
skeletal muscle, adipose tissue, skin, connective tissue, cartilage, bone marrow stroma, vascular 
endothelia as well as mouse and human embryonic stem cells [23-45].  Many of the cell types that 
can be efficiently transfected by nucleofection are extremely difficult or impossible to transfect using 
other non-viral methods. 
 Given Nucleofection's track record, we tested whether it would be an efficient method for the 
routine transfection of thymic epithelial cells.  We found that nucleofection does result in high 
efficiency transfection of TEC lines as well as primary TECs.  We also found that reproducible high 
efficiency transfection was possible while preserving cell viability.  Our studies indicate that 
nucleofection greatly increases the feasibility of studies that require the transfection of multiple 
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independent constructs into thymic epithelial cells.  This simple and high efficiency transfection 
method will facilitate the analysis of gene regulatory regions of TEC genes as well as the analysis of 
the functional domains of proteins that are necessary for TEC development and function. 
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Results and Discussion 
Thymic epithelial cell lines can be transfected at high efficiency via Nucleofection. 
 To test whether Nucleofection could be used to efficiently transfect a range of different 
thymic epithelial cell lines we examined the Nucleofection efficiency of four different TEC lines 
(TE-71, Z210R.1, 100-4, 41.2).  The TE-71 and Z210R.1 TEC lines were derived from normal adult 
Balb/c mice and were typed as medullary epithelium [46].  The 100-4 and 41.2 cell lines were 
derived from C3HXC57B1/6 mice and were derived from cortical epithelium [47, 48]. 
Our initial goal was to test several different Nucleofector programs to define an optimal 
program for each of the four cell lines tested.  To do this we used a reagent kit that had been 
recommended by Amaxa support staff for the optimization of conditions for epithelial cell lines (kit 
V).   For each cell line we measured the transfection efficiency and cell survival with the same set of 
6 different Nucleofector programs.  Using this approach, we identified conditions for the high 
efficiency transfection of all four TEC lines with low cell mortality.  For each Nucleofector program 
we found that the maximum transfection efficiency differed between the cell lines.   However, we 
found that for all cell lines, program T-30 resulted in the most efficient transfection with the lowest 
amount of cell death (Figure 1 A, B).  
 Once we had identified T-30 as an optimal Nucleofection program for the TEC lines we then 
performed additional experiments to determine the reproducibility of TEC line Nucleofection.  We 
measured the transfection efficiency as the percentage of GFP positive cells that had survived for 24 
hours after Nucleofection by flow cytometry (Figure 1C).  We found that our Nucleofection 
conditions resulted in mean transfection efficiencies of 30% to 70% for the four TEC lines. (Figure 
1E).  We also found that the reproducibility of Nucleofection efficiencies varied between the 4 cell 
lines with the range of the efficiency being smaller for the TE-71 and 100-4 cell lines  than for the 
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Z210r.1 and 41-2 cell lines (Figure 1E).  Cell survival in all cases was excellent, with greater than 
85% of the cells surviving for 24 hours after Nucleofection of each cell line (Fig. 1D).  We also 
tested whether the transfection efficiency would vary with cell density.  We found that Nucleofection 
of fewer than 1.5 x 106 cells from each TEC line resulted in greatly reduced cell survival 
immediately after Nucleofection and that cell survival greatly improved as the sample size reached 4 
X 106 cells with no loss of efficiency (data not shown).  Excellent viability and proliferation were 
observed for each of the four cell lines for up to 7 days after the procedure.  
 Primary TEC cultures are also used for studies of thymic development and function [49, 50].   
Primary TEC cultures can be established from fetal as well as adult thymus.  Unfortunately, TECs 
are a tiny minority of the cells in the thymus making it difficult to isolate large numbers of cells for 
primary culture.  Therefore, high efficiency transfection methods that produce minimal cell mortality 
are an absolute necessity for experiments with primary thymic epithelial cells.  We started our tests 
of primary TEC Nucleofection with cells isolated from E15.5 day fetal thymuses.  At this stage there 
is a relatively large number of proliferating TECs while T-cell number is relatively low [51].  In an 
initial experiment to identify optimal Nucleofection conditions for primary fetal TECs, we tested 
several Nucleofector programs.  The programs T-13, T-20 and U-17 resulted in high levels of cell 
death with less than 10% of the cells surviving the procedure.  However, we found that there was a 
trade-off between cell death and transfection efficiency, with programs T-13 and U-17 resulting in 
about 50% of the surviving cells being GFP+.  In contrast, transfection with program S-05 resulted in 
greater than 30% cell survival the with about 30% of the surviving cells being GFP+ (Figure 2, A-C).  
To quantify the absolute efficiency of each program, the total number of GFP expressing cells was 
taken as a ratio of the total number of viable cells in an untransfected control (Figure 2 C). Using this 
analysis it was determined that, of the programs tested, program S-05 was the most efficient program 
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for Nucleofection of E15.5 mouse fetal primary TECs using the Nucleofector solution V.   
 Upon determination that program S-05 gave the highest transfection efficiency with good cell 
viability, we performed additional transfections to determine the reproducibility of this protocol with 
E15.5 day primary TECs.  It was found that consistent levels of viability and GFP expression could 
be achieved with program S-05 with values similar to that found in the optimization experiments 
(data not shown).  Cytokeratin immunostaining confirmed that nearly all of the cells in the cultures 
expressed cytokeratin, indicating that they are TECs (Figure 2A). 
 We also tested the efficiency of Nucleofection for the transfection of primary TECs isolated 
from postnatal thymuses.   We tested the Nucleofection programs T-13 and S-05 on TEC cultures 
prepared from 3 day old (P3) and 30 day old (P30) postnatal Swiss Webster mice (Figure 2).   We 
found that the P3 TECs were efficiently transfected, with about 25% of the viable cells expressing 
GFP (figure 2 D-F).  However, we found that the nucleofection conditions had to be modified for the 
older primary TECs isolated from 30 day old thymuses.  With the earlier stages we had used 
Nucleofection solution V, but for 30 day old postnatal primary cells use of this solution resulted in 
extremely low transfection efficiencies of around 1% of the viable cells (data not shown).  To 
improve the transfection efficiency for  the TECs from 30 day old mice we tested the primary 
epithelial cell Nucleofection  solution with this cell type.  We found that using program T-13 we 
were able to get high efficiency transfection with about 40% of the viable cells expressing GFP but 
with only 20% of the starting cell population remaining viable (figure 2 G-I).  Although 
nucleofection of these later stage primary TECs results in greater cell death, the efficiency is quite 
high.  Again, staining with pan-cytokeratin confirmed that the cells are TECs (figure 2G). 
Our results show that Nucleofection enables the high efficiency transfection of  primary TEC 
as well as cell lines derived from thymic epthelial cells.  This cell type is difficult to transfect by 
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methods typically used for routine transfection such as lipofection.  A previous report described an 
efficient method for retrovirus-mediated transfection of primary TECs [22].  This method results in 
stable transfection of about 30% of the E15.5 TECs used in the study [22].  Retroviral transfection is 
an excellent choice for the generation of stable transfected cell lines but it is cumbersome for routine 
transient transfection studies. Retroviral vector production for TEC transfection requires the 
transfection of the viral packaging cell line, enrichment of the transfected cells and centrifugation to 
concentrate the viral particles [22].  Since most studies that use transient transfection utilize many 
expression and/or reporter constructs, retroviral transfection of TECs would be laborious and 
expensive. 
 In contrast, the high efficiency achieved by Nucleofection of TECs makes it feasible to 
perform any type of analysis that requires repeated transfections of many plasmid constructs.    In 
comparison with lipofection we find that nucleofection results in greater cell viability and much 
greater transfection efficiency.  For example, in our lab lipofectamine-mediated transfection of TECs 
results in a transfection efficiency of  3-5% using the same TEC lines that we used in this study (data 
not shown).  Our finding that Nucleofection can transfect thymic epithelial cells with high efficiency 
and relatively low cell mortality adds another method to the rapidly developing molecular genetic 
toolkit for studies of thymic epithelial cells.  Existing genetic tools for the manipulation of TEC 
biology include retroviral transfection methods as well as mouse strains that express GFP, Cre 
recombinase and cyclin D1 in all or some TEC populations and the identification of loci that can be 
used to drive gene expression in all or a defined subset of the TECs in vivo [22, 52-57].  By applying 
Nucleofection to the study of TEC biology we have enabled additional avenues for the molecular 
analysis of the development and function of this crucial cell type in cell culture. 
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Conclusions 
 Thymic epithelial cells can be readily transfected at high efficiency by Nucleofection.  
Efficient transfection can be performed with established cortical and medullary thymic epithelial cell 
lines as well as primary TECs isolated from E15.5 day fetal thymus or postnatal day 3 or 30 thymus 
tissue.  Transfection efficiencies as high as 70% of the surviving cell population can be achieved 
reproducibly.  Nucleofection will enable high throughput transfection-based studies of TEC gene 
regulation, cell biology and differentiation.   
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Methods 
Culture of TEC lines and the preparation and culture of primary TECs.  
 The  four TEC lines used in this work (100-4, Z210R.1, TE-71, 41.2) were obtained from Dr. 
Andrew Farr, Dept. of Immunology, University of Washington School of Medicine.  All TEC lines 
were cultured on T-75 tissue culture flasks (Nunc) in RPMI 1640 (Invitrogen)  medium with 10% 
fetal bovine serum (Invitrogen), 2 mM L-Glutamine (Invitrogen), 50 units/ml Penicillin and 50 
µg/ml Streptomycin (Invitrogen).  Each cell line was passaged into 2 T-75 flasks at 4 X106 cells per 
flask and incubated at 37oC in 5 % CO2 for 48 hours prior to Nucleofection.  After 48 hours of 
incubation, cells were 80-90% confluent and each flask contained 8 X 106 to 1.4 X 107 cells. Cells 
were trypsinized with 0.25% trypsin/EDTA (Invitrogen) and resuspended in aliquots of 2 X 106 cells 
per 2 ml of media for nucleofection.  
 To generate fetal primary TEC cultures, thymi were removed from E15.5 C57Bl/6 embryos 
and placed directly in ice-cold TEC-10 media containing RPMI 1640 (Invitrogen)  medium with 
10% fetal bovine serum (Invitrogen), 2 mM L-Glutamine (Invitrogen), 50 units/ml Penicillin and 50 
ug/ml Streptomycin (Invitrogen).  Immediately after removal thymi were incubated for 15 min at 
room temperature in 2 mg/ml papain (Worthington Biochemical, Lakewood NJ) in RPMI-1640.  The 
Papain reaction was stopped by adding 1 volume of TEC-10 media and the tissue was then broken up 
by trituration.  Cells were then plated on a 10 cm tissue culture plate (Nunc) in 10 ml of TEC-10. The 
cells were allowed to grow for 3 days in original media. After three days the media was changed to 
eliminate thymocytes. Cells were maintained in culture for fewer than 7 days and were not passaged 
prior to Nucleofection. 
 For primary culture of postnatal TECs, thymuses were removed from 3 day old or 30 day old 
Swiss Webster mice.  After removal, thymuses were placed in TEC-10 medium and allowed to settle 
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in a 15 ml tube for 5-10 mins.  The thymuses were rinsed in three successive changes of TEC-10 
medium to remove non-thymic cell types clinging to the surface.  Cells were isolated by digesting 
the thymus tissue with 0.2 mg/ml collagenase D in RPMI-1610 containing 2% fetal bovine serum, 
20mM HEPES  at 25oC for 20 mins.  The tissues was then incubated in a medium containing RPMI-
1610, 2% fetal bovine serum, 20mM HEPES, 0.2 mg/ml collagenase, 0.2 mg/ml dispase and 
25µg/ml DNase I for 40 mins at 37oC.  Five volumes of TEC-10 medium was added to stop the 
enzymes and the tissue clumps were broken up by trituration.  The resulting cell suspension (from 8-
11 thymuses) was plated onto a 10 cm tissue culture plate.   
Nucleofection of TEC lines and primary thymic epithelial cells. 
 Nucleofection of the thymic epithelial cell lines and primary TECs was performed using the 
Amaxa Nucleofector II device.  Based on technical advice from Amaxa Inc. support staff we used 
the cell line Nucleofection kit V to optimize conditions for the 4 TEC lines.  Seven samples each 
containing 2 X 106 cells were prepared for each cell line and each sample was Nucleofected using 
one of 6 different programs (A-20, T-20, T-30, X-01, X-05, D-23) with the untransfected sample 
serving as a control.  Nucleofections were performed according to Amaxa's recommendations with 
5µg of pmaxGFP.  The pmaxGFP plasmid contains a CMV promoter driving a Pontellina (copepod) 
green fluorescent protein coding sequence [58] and an SV40 poly A site (Amaxa News #3).  After 
each sample was transfected it was immediately transferred to 1 ml of culture media that had been 
warmed to 37o C and placed in an incubator (37oC, 5% CO2) until all samples were ready for plating.  
For each sample, half of the cells were plated and the medium was changed after 3-5 h to remove 
dead cells. The plates were incubated for 24 h and then fixed in 1% paraformaldehyde in 1X PBS 
and stored at 8o C for flow cytometry analysis. The other half of each sample was stained with 
propidium iodide (Sigma) immediately after Nucleofection for flow cytometry analysis of cell 
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mortality due to the procedure. 
 Primary thymic epithelial cells were maintained in TEC-10 media in 10 cm tissue culture 
dishes (Nunc). For optimization experiments the primary TECs were divided into 5 samples of  
2 X 106 cells each. The samples were suspended in 100µl of solution V (Amaxa Inc.) containing 1µg 
of pmaxGFP plasmid and subjected to one of four Nucleofector programs as recommended for 
primary epithelial cells (S-05, T-13, T-20, X-05).  One sample was not transfected and served as a 
negative control. Each sample was seeded into one well of a 6 well tissue culture plate (Nunc) and 
allowed to grow for 24 hours before observing GFP expression.  For cell counts, the transfected cells 
were plated on microscope slides in 250 µl droplets and allowed to attach for 24 hours.   
Cell counting and flow cytometry.  
 The efficiency of pmaxGFP transfection of the cell lines was measured using a FACScalibur 
cytometer (Becton Dickenson) and the data were analyzed using FloJo software.  Cell death resulting 
from each transfection was measured by counting the number of cells that were stained by propidium 
iodide in each sample immediately after Nucleofection.  Propidium iodide stock solution (1 mg/ml 
Sigma) was diluted in 1X PBS to 1µg/ml. Medium was removed from each sample by centrifugation. 
The cell samples were resuspended in 500µl of propidium iodide staining solution (1µg/ml 
propidium iodide in PBS) and allowed to incubate at room temperature for 30 minutes.  The cells 
were pelleted, resuspended in cold PBS and analyzed by flow cytometry within 30 mins. 
 The transfection efficiency of the primary cells was measured by counting cells in multiple 
microscope fields of transfected samples and untransfected control samples.  After 24 hours of 
culture, half of the samples were fixed with acetone and cytokeratins were detected using a pan-
cytokeratin polyclonal primary antibody (Dako) and a secondary antibody conjugated to texas red 
(Jackson ImmunoResearch).  The remaining samples were not fixed with acetone so that GFP 
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expression could be observed for counting.  All samples were stained with DAPI using DAPI 
containing aqueous mounting media (Invitrogen) so that nuclei could be visualized for cell counts.  
To measure GFP expression 10 micrographs were taken of each sample and the cells were counted.  
To measure viability, mean total cell numbers in transfected samples and in untransfected controls 
were determined. 
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Figure Legends 
Figure 1.  Efficient transfection of four different thymic epithelial cell lines by Nucleofction. 
(A, B) GFP expression (B) 24 hours after Nucleofection (program T-30) of the pmaxGFP plasmid 
into the thymic epithelial cell line 41-2 which was derived from cortical thymic epithelium;  
(A)  brightfield phase-contrast image of the same field shown in B. 
(C) Results of flow cytometry performed 24 hours after Nucleofection.  The data shown are 
representative results for a single experiment with the 41-2 TEC line and Nucleofection program  
T-30.  The top row of plots show propidium iodide staining profiles for the untransfected (left panel) 
and transfected (right panel) cells.   The bottom row shows the GFP staining profiles for 
untransfected (left panel) and pmaxGFP transfected (right panel) 41-2 cells.  (D, E)  Overall cell 
death as measured by propidium iodide staining (D) and the percentage of the  cells expressing GFP  
the four TEC lines tested (E).  Bars indicate the range of the average values obtained by flow 
cytometry.   
Figure 2.  Efficient transfection of primary thymic epithelial cells by nucleofection. 
Thymic epithelial cell cultures were isolated from E15.5 day embryos, 3 day postnatal pups, and 30 
day old mice.  
(A, D, G)  Detection of cytokeratin by a pan-cytokeratin antibody reveals that most of the cells in the 
primary cultures are TECs.  Primary TECs from E15.5 (A), postnatal day 3 (D) and postnatal day 30 
(G) animals are shown.   
(B, E, H)  Expression of the pmaxGFP plasmid in transfected primary TECs from E15.5 (B), 
postnatal day 3 (E) and postnatal day 30 (H) animals are shown. 
(C, F, I)  Results from representative Nucleofections of primary TECs.  Each bar on the bar graph 
shows the proportion of cells that survived Nucleofection as compared to untransfected control 
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cultures.  Each bar is divided into the proportion of cells expressing GFP (red segment of each bars) 
as well as the proportion that did not express GFP (blue segment of each bar.  In the case of primary 
TECs derived from E15.5 fetal thymi the transfection results are shown for Nucleofection programs 
S-005, T-013, T-030 and U-027 (C).   
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